Oncos Therapeutics oncos.com


Public list: Pharma Startups (4732) Cancer Therapeutics (1137)

Oncos is a privately funded clinical-stage biotechnology company focused on the development and commercialization of targeted cancer immunotherapy. Oncos' product candidates induce a tailored response by the immune system directed at each patient's unique cancer cells. Oncos' lead product candidate, ONCOS-102, has successfully completed Phase I clinical studies. Additionally, a promising pipeline has been developed using Oncos' patented adenovirus-based cancer immunotherapy platform, for the tre...Show all

Oncos is a privately funded clinical-stage biotechnology company focused on the development and commercialization of targeted cancer immunotherapy. Oncos' product candidates induce a tailored response by the immune system directed at each patient's u...Show all

Company (Merged)

Phone:

Fax:

Saukonpaadenranta 2

Helsinki, FI-00180
Finland

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Oncos Therapeutics $0M Jun 12, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Oncos Therapeutics Jobs

jobs by Indeed job
						search
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Recombinant serotype 5 (ad5) adenoviral vectors Nov 23, 2012 Aug 09, 2016 Patent
Recombinant serotype 5 (ad5) adenoviral vectors Sep 25, 2015 Application
Adenoviral vectors and methods and uses related thereto Nov 11, 2014 Application